A prospective cohort study investigating readmission,symptom attribution and psychological health within six months of primary percutaneous coronary intervention

Abstract

Aims:

Following primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction, some patients are readmitted with potential ischaemic heart disease symptoms. This study investigated the proportion of PPCI patients readmitted due to potential ischaemic heart disease symptoms within six months, and the cause of symptoms and associated factors.

Methods and results:

A prospective cohort study included consecutive PPCI patients. Baseline variables incorporated the Global Registry of Acute Coronary Events, the Charlson Comorbidity Index and self-report measures ENRICHD Social Support Inventory, Seattle Angina Questionnaire (SAQ) and Hospital and Anxiety and Depression Scale (HADS). At six months, repeat SAQ, HADS and readmission data were collected. Of 202 PPCI patients (mean 59.7 years (SD 13.9), 75.7% male), 38 (18.8%; 95% confidence interval 14.0–24.8%) were readmitted due to potential ischaemic heart disease symptoms (16 cardiac events, 22 indeterminate diagnosis) at six months. Mean HADS anxiety scores were higher for the readmission compared with the non-readmission group (baseline 9.5 vs. 7.1, p=0.006; six months 9.4 vs. 6.0, p<0.001). Angina symptoms were stable and infrequent throughout for both groups. Logistic regression modelling, including predictors HADS anxiety, SAQ angina stability, SAQ angina frequency, the Global Registry of Acute Coronary Events and the Charlson Comorbidity Index, determined HADS anxiety as a predictor of readmission with adjusted odds ratio of 1.12 (95% confidence interval 1.03–1.22, p=0.008).

Conclusion:

One in six patients were readmitted due to potential ischaemic heart disease symptoms, with the largest proportion receiving an indeterminate readmission diagnosis. Elevated levels of anxiety at baseline were predictive of readmission with potential ischaemic heart disease symptoms at six months.

Keywords

Myocardial infarction primary percutaneous coronary intervention symptom attribution chest pain readmission anxiety psychological health

Get full access to this article

View all access options for this article.

References

Dammen

Arnesen

Ekeberg

. Psychological factors, pain attribution and medical morbidity in chest-pain patients with and without coronary artery disease. Gen Hosp Psychiatry 2004; 26 463-469.

Mayou

Gill

Thompson

. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000; 62: 212-219.

Ros

Armengol

Grande

. Chest pain at rest in patients with coronary artery disease myocardial ischemia, esophageal dysfunction, or panic disorder? Dig Dis Sci 1997; 42: 1344-1353.

Lambert

Brown

Segal

Brophy

. Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction. JAMA 2010; 303: 2148-2155.

Antman

Hand

Armstrong

. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-elevation Myocardial Infarction: A report of the ACC/AHA Task Force on Practice Guidelines. Circulation 2008; 117: 296-329.

Ortolani

Marzocchi

Marrozzini

. Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: Results of a registry study in an ST-elevation myocardial infarction network. Eur Heart J 2009; 30: 33-43.

Grace

Abbey

Irvine

. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother Psychosom 2004; 73: 344-352.

Grace

Abbey

Pinto

. Longitudinal course of depressive symptomatology after a cardiac event: Effects of gender and cardiac rehabilitation. Psychosom Med 2005; 67: 52–58.

Austin

Adam

Shome

. Route of admission in STEMI: Do patients who present directly to a PCI-capable hospital differ from inter-hospital transfers? Heart 2011; 97(Suppl. 1): A5.

10.

Jakobsen

Niemann

Pedersen

. Comparison of primary percutaneous coronary intervention in real-world populations versus clinical trial populations. Am J Cardiol 2010; 105: 1684-1691.

11.

Mehran

Lansky

Witzenbichler

. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 2009; 374: 1149-1159.

12.

Frasure-Smith

Lesperance

Talajic

. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993; 270: 1819-1825.

13.

Lane

Carroll

Ring

. Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction. J Psychosom Res 2000; 49: 229-238.

14.

Cossette

Frasure-Smith

Lesperance

. Clinical implications of a reduction in psychological distress on cardiac prognosis in patients participating in a psychosocial intervention program. Psychosom Med 2001; 63: 257-266.

15.

DeVon

Ryan

Ochs

. Symptoms across the continuum of acute coronary syndromes: Differences between women and men. Am J Crit Care 2008; 17: 14-25.

16.

Sampson

O’Cathain

Goodacre

. Feeling fixed and its contribution to patient satisfaction with primary angioplasty: A qualitative study. Eur J Cardiovasc Nurs 2009; 8: 85-90.

17.

Keeley

Boura

Grines

. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.

18.

Astin

Closs

McLenachan

. Primary angioplasty for heart attack: Mismatch between expectations and reality? J Adv Nurs 2009; 65: 72-83.

19.

Astin

Closs

McLenachan

. The information needs of patients treated with primary angioplasty for heart attack: An exploratory study. Patient Educ Couns 2008; 73: 325-332.

20.

Raosoft®, http://www.raosoft.com/samplesize.html (2006, accessed 1 September 2006).

21.

GUSTO IIb Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336: 1621-1628.

22.

Stone

Grines

Cox

. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002; 346: 957-966.

23.

Fox

KAA

Dabbous

Goldberg

. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: Prospective multinational observational study (GRACE). BMJ 2006; 25; 333: 1091-1094.

24.

Charlson

Pompei

Ales

. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383.

25.

National Institute for Health and Clinical Excellence. Unstable angina and NSTEMI: The early management of unstable angina and non-ST-segment-elevation myocardial infarction, www.nice.org.uk/guidance/CG94 (2010, accessed 1 May 2010).

26.

National Institute for Health and Clinical Excellence. Chest pain of recent onset: Assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin, www.nice.org.uk/guidance/CG95 (2010, accessed 1 May 2010).

27.

Deaton

Thourani

. Patients with type 2 diabetes undergoing coronary artery bypass graft surgery: Predictors of outcomes. Eur J Cardiovasc Nurs 2009; 8: 48-56.

28.

Institute for Algorithmic Medicine. An on-line calculator for the Charlson Comorbidity Index, http://www.medal.org/OnlineCalculators/ch1/ch1.13/ch1.13.01.php#result (accessed 1 November 2006).

29.

Zigmond

Snaith

. The Hospital Anxiety and Depression Scale. Acta Psych Scand 1983; 67: 361-370.

30.

Mortensen

Bjorner

Oldenburg

. Health-related quality of life one month after thrombolysis or primary PCI in patients with ST-elevation infarction. A DANAMI-2 sub-study. Scand Cardiovasc J 2005; 39: 206–212.

31.

Strik

JJMH

Honig

Lousberg

. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 2001; 42: 423-428.

32.

Spertus

Winder

Dewhurst

. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol 1995; 25: 333–341.

33.

Norris

Saunders

Ghali

. Health-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical management. Can J Cardiol 2004; 20: 1259-1266.

34.

Oesterle

Sanborn

Ali

. Percutaneous transmyocardial laser revascularisation for severe angina: The PACIFIC randomised trial. Lancet 2000; 356: 1705-1710.

35.

Mitchell

Powell

Blumenthal

. A short social support measure for patients recovering from myocardial infarction: The ENRICHD Social Support Inventory. J Cardiopulm Rehabil 2003; 23: 398-403.

36.

McHorney

Ware

Jr Raczek

. The MOS 36-Item Short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-263.

37.

Vaglio

Conard

Poston

. Testing the performance of the ENRICHD Social Support Instrument in cardiac patients. Health Qual Life Outcomes 2004; 2, http://www.hqlo.com/content/2/1/24 (accessed 14 December 2006).

38.

Dickens

McGowan

Percival

. Lack of a close confidant, but not depression, predicts further cardiac events after myocardial infarction. Heart 2004; 90: 518-522.

39.

Berkman

Blumenthal

Burg

.; Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD). Effects of treating depression and low perceived social support on clinical events after myocardial infarction. The enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. J Am Med Assoc 2003; 289: 3106-3116.

40.

Peduzzi

Concato

Kemper

. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49: 1373-1379.

41.

Vittinghoff

McCulloch

. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007; 165: 710-718.

42.

Nagelkerke

NJD

. A note on a general definition of the coefficient of determination. Biometrika 1991; 78: 691-692.

43.

Strik

JJMH

Denollet

Lousberg

. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol 2003; 42: 1801-1807.

44.

Roest

Martens

Denollet

. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: A meta-analysis. Psychosom Med 2010; 72: 563-569.